1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Diagnostics & Research
Exact Sciences Corporation

Exact Sciences Corporation

EXAS
Exact Sciences CorporationUS flagNASDAQ Capital Market
104.91
USD
- -
- -
20.03BMarket Cap

Total Valuation

Exact Sciences Corporation carries a market capitalization of 20.03B, placing it among publicly traded companies globally. Its enterprise value stands at 20.68B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap20.03B
Enterprise Value20.68B

Share Statistics

Exact Sciences Corporation currently has 190.80M shares outstanding.

Shares Outstanding190.80M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

The price-to-sales ratio is 5.89, and the price-to-book ratio stands at -4.07.

PE RatioN/A
PS Ratio5.89
PB Ratio-4.07
P/TBV Ratio-21.56
P/FCF Ratio33.85
P/OCF Ratio38.92

Enterprise Valuation

On an enterprise value basis, Exact Sciences Corporation trades at an EV/EBITDA multiple of 920.08 and an EV/FCF ratio of 35.11.

EV / Sales6.37
EV / EBITDA920.08
EV / EBITN/A
EV / FCF35.11

Financial Position

Exact Sciences Corporation maintains a current ratio of 2.43, meaning it holds 2.4x the short-term assets needed to cover near-term liabilities. The debt-to-equity ratio is 105.07, indicating elevated leverage, while an interest coverage ratio of 0.95 demonstrates limited ability to service its debt obligations.

Current Ratio2.43
Quick Ratio1.97
Debt / Equity105.07
Debt / EBITDA112.21
Interest Coverage0.95

Financial Efficiency

Return on Equity (ROE)N/A
Return on Assets (ROA)-3.53
Return on Invested Capital (ROIC)N/A
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover5.99

Taxes

Income Tax4.06M
Effective Tax RateN/A

Stock Price Statistics

Exact Sciences Corporation's stock has gained approximately 137.62174% over the past 52 weeks. The 50-day moving average sits at 103.02, while the 200-day moving average is 74.29.

Beta (5Y)N/A
52-Week Price Change137.62174%
50-Day Moving Average103.02
200-Day Moving Average74.29
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, Exact Sciences Corporation generated 3.25B in revenue and converted that into -207.95M in net income, yielding earnings per share of -1.10. EBITDA reached 22.48M, while operating income came in at -199.10M.

Revenue3.25B
Gross Profit2.26B
Operating Income-199.10M
Pretax Income-203.89M
Net Income-207.95M
EBITDA22.48M
EBIT-199.10M
Earnings Per Share (EPS)-1.10

Balance Sheet

Exact Sciences Corporation holds 964.71M in cash and equivalents against 2.52B in total debt, resulting in a net debt position of 1.37B. Total book value stands at -4.70B, with working capital of 914.70M providing operational flexibility.

Cash & Cash Equivalents964.71M
Total Debt2.52B
Net Debt1.37B
Equity (Book Value)-4.70B
Book Value Per Share-24.98
Working Capital914.70M

Cash Flow

Exact Sciences Corporation produced 491.44M in operating cash flow over the past twelve months. After subtracting -73.52M in capital expenditures, free cash flow totaled 417.92M - equivalent to 2.22 per share.

Operating Cash Flow491.44M
Capital Expenditures-73.52M
Free Cash Flow417.92M
FCF Per Share2.22

Margins

Exact Sciences Corporation operates with a gross margin of 69.69, reflecting its pricing power and cost economics. The operating margin of -6.13 and net profit margin of -6.40 provide insight into operational efficiency.

Gross Margin69.69
Operating Margin-6.13
Pretax Margin-6.28
Profit Margin-6.40
EBITDA Margin0.69

Dividends & Yields

Dividend Per ShareN/A
Dividend YieldN/A
Payout RatioN/A
Shareholder Yield1.77
FCF Yield2.95

Scores

Exact Sciences Corporation posts an Altman Z-Score of 2.19, near the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score2.19